Insights from CURE: Using clopidogrel on top of standard therapy

Cerebrovascular Diseases

Volumn 13, Issue SUPPL. 1, 2002, Pages 17-21

  Morais, João ^a  

^a Cardiology Division   (Portugal)

Author keywords

Clopidogrel; CURE; Myocardial infarction; Unstable angina

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

ADULT; AGED; ARTERY THROMBOSIS; ATHEROSCLEROTIC PLAQUE; BLEEDING; BRAIN HEMORRHAGE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; Q WAVE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; STROKE; THROMBOCYTE RICH PLASMA; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS;

AGED; ANGINA, UNSTABLE; ASPIRIN; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HEPARIN; HUMANS; INTRACRANIAL ARTERIOSCLEROSIS; INTRACRANIAL THROMBOSIS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; RECURRENCE; SURVIVAL ANALYSIS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 0036156439     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000047785     Document Type: Conference Paper

References (25)

1. Acute coronary syndromes. Unstable angina and non-Q-wave myocardial infarction
2. Management of acute coronary syndromes: Acute coronary syndromes without persistent ST segment elevation. Recommendations of the Task Force of the European Society of Cardiology
3. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina)
4. Invasive compared with non-invasive treatment in unstable coronary-artery disease: FRISC II prospective randomized multicentre study
5. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban
6. Variations between countries in invasive cardiac procedures and outcomes in patients with suspected unstable angina or myocardial infarction without initial ST elevation
7. Long-term low-molecular-mass heparin in unstable coronary-artery disease: FRISC II prospective randomized multicentre study
8. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction
9. Increased mortality with oral platelet glycoprotein IIb/IIIa antagonists: A meta-analysis of phase III multi-center randomized trials
10. Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis
11. Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates
12. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit
13. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans
14. Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: Enhanced inhibitory effects of combination therapy
15. A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents
16. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet in unplanned and elective coronary stenting. The Full Anticoagulation versus Aspirin plus Ticlopidine (FANTASTIC) study
17. Randomized evaluation of anticoagulation versus antiplatelet therapy after coronary stent implantation in high-risk patients: The multicenter aspirin and ticlopidine trial after intracoronary stenting (MATTIS)
18. A clinical trial comparing three antithrombotic-drug regimes after coronary-artery stenting
19. Double-blind study of the safety of clopidogrel with and without a loading dose in combination with aspirin compared with ticlopidine in combination with aspirin after coronary stenting: The Clopidogrel Aspirin Stent International Cooperative study (CLASSICS)
20. A randomized comparison of clopidogrel and aspirin versus ticlopidine and aspirin after the placement of coronary-artery stents
21. Randomized comparison of ticlopidine and clopidogrel after intracoronary stent implantation in a broad patient population
22. Clopidogrel instead of ticlopidine after coronary stent placement: Is the switch justified?
23. Reduction in major adverse cardiac events, including mortality, after stenting using clopidogrel instead of ticlopidine
24. The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
25. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation